Research dossier
Epitalon — tetrapeptide and telomerase expression dossier
A short tetrapeptide studied for its reported influence on telomerase expression.
Translated from the French original, which remains the reference version: lire en français →
Molecular identity
| Parameter | Value |
|---|---|
| CAS number | 307297-39-8 |
| Molar mass | 390.39 g/mol |
| Molecular formula | C₁₄H₂₂N₄O₉ |
| Sequence / nature | Ala-Glu-Asp-Gly |
| Purity | ≥99% |
| Appearance | White lyophilised powder |
The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.
Research context
Short regulatory peptides are a school of research developed largely in a specific national context, with its own methodologies and publication standards. Approaching that literature requires knowing its conventions; applying it without that precaution leads to excessive interpretation in either direction.
Mechanism studied
Epitalon is a tetrapeptide of sequence Ala-Glu-Asp-Gly (AEDG), arising from the Russian work on short regulatory peptides. Its very low molecular mass places it at the lower limit of what is usually called a bioactive peptide.
The dominant mechanistic hypothesis in the literature is a direct interaction with DNA. Molecular modelling work and gel shift assays have examined the ability of short peptides rich in acidic residues to bind the DNA groove at specific promoter sequences, with modulation of transcription as the proposed consequence — notably of the hTERT gene, the catalytic subunit of telomerase.
The in-vitro measurements reported include telomerase activity assay by TRAP (telomeric repeat amplification protocol) and quantification of telomere length by qPCR on fibroblast cultures in replicative senescence.
In-vitro literature
A substantial part of the literature is published in Russian, which limits its accessibility and independent replication. That limit must be taken into account in any review of the literature on this compound.
Bibliographic entry points
- PubMed — peer-reviewed literature
- PubChem — chemical profile and assay data
- NCBI — methodology and receptor references
These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.
Distinguishing this compound from its analogues
Sequence AEDG, to be distinguished from pinealon (EDR) and the other short peptides of the same series. These compounds are frequently and wrongly grouped under a common label.
The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.
Methodological limits
Two limits compound each other: the restricted accessibility of a substantial part of the literature, published in Russian, and the methodological weakness of some older protocols by current standards. TRAP assays of telomerase activity are also sensitive to inhibitors present in extracts, a well documented source of false negatives.
These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.
Analytical parameters
A very polar tetrapeptide, weakly retained in reversed phase. The chromatographic method must be adapted, since a standard C18 gradient can produce an early, poorly resolved elution.
| Parameter | Value |
|---|---|
| Storage | Store at −20 °C, protected from light |
| Solubility | Soluble in bacteriostatic water (BAC) |
| Stability | Stable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C |
| Control methods | RP-HPLC · MS · NMR |
Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.
Resulting concentrations
The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.
| Format | 1 ml | 2 ml | 3 ml |
|---|---|---|---|
| 10mg | 10.00 mg/ml | 5.00 mg/ml | 3.33 mg/ml |
| 50mg | 50.00 mg/ml | 25.00 mg/ml | 16.67 mg/ml |
These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.
Protocol design
Three points govern the validity of an assay using this material, whatever the question being asked.
The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.
The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.
The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.
Lot verification
The following formats are covered by a Janoshik Analytical report, readable from the product page:
- 10mg — lot report available
- 50mg — lot report available
| Format | Lot report | Availability |
|---|---|---|
| 10mg | Covered | In stock |
| 50mg | Covered | In stock |
The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.
Frequently asked questions
How does this product arrive?
As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.
Which solvent should be used for reconstitution?
Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.
How long does the material remain stable?
The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.
Does the analysis report correspond exactly to my vial?
The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.
Can this product be used on humans or animals?
No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.
Dossiers in the same category
- MOTS-c — CAS 1627580-64-6